Intellectual property covers your business's intangible assets, including patents, copyrights, and trade secrets.
For founders, the biggest risk isn't waiting too long to file; it's accidentally "starting the clock" on your one-year patent window through public disclosures, including workshopping ideas with AI tools.
Most product tweaks qualify as innovative even if they don't feel groundbreaking, and a patent-pending filing lets you start marketing immediately.
IP strategy should be prioritized based on funding stage, not treated as one-size-fits-all.
Intellectual property refers to a business's intangible assets: patents, copyrights, and trade secrets. Each protects a different kind of innovation, and together they form the legal foundation that lets a founder claim ownership of what they've built. For early-stage companies, IP isn't just about defense — it can signal credibility to investors and create real revenue opportunities through licensing.
There's no universal answer. Timing depends on two factors: how far along the business is in funding, and how developed the innovation is. Some founders should engage counsel as soon as they have a single invention, both to protect it and to map the "white space" in their market as they build. Others can wait until after securing funding.
In the US, founders have a one-year window to pursue patent protection after a "public disclosure." That clock starts the moment information goes public — through a sale, a demo, or a presentation without confidentiality protections in place. Before initiating an NDA or working with counsel, any conversation with a potential partner or production team carries risk.
This is still an evolving legal question. Recent rulings suggest conversations with AI tools may be discoverable, which raises real questions about what founders put into a prompt. There's also a separate issue: patent law requires a human inventor. AI can be a powerful tool for workshopping an idea, but it can't be credited as the inventor, and founders need to clearly document what is their own contribution versus AI-generated output.
Many founders assume their idea isn't innovative enough to patent. But the patent office's bar for innovation is lower than most people assume — it doesn't require a groundbreaking technological leap. A small, well-executed tweak to an existing product can qualify, and those incremental innovations are often the most commercially valuable, since timing and market readiness matter as much as novelty.
Both. Litigation gets the attention, but it's expensive and usually reserved for larger players. The more practical upside for early-stage companies is defensive-offensive: a patent lets you license your innovation for revenue, and it gives you a documented "stake in the ground" proving you aren't infringing on someone else's work — something that becomes more valuable as the company grows or approaches an exit.
Start with a conversation, not a filing. A good IP strategy begins by mapping the business as it exists now, where it's headed, and how it's funded — bootstrapped, family raise, or formal investment. From there, an attorney can help prioritize: not every founder needs a patent immediately, and complexity of the product plays a major role in that decision.
Once a filing date is secured with the USPTO, a product can be marketed as "patent pending" right away — founders don't need to wait for full approval to start building momentum. Any new implementations not covered in the original filing should stay confidential until they're properly protected.
This is one of the more misunderstood parts of the process. In everyday language, "obvious" means simple or predictable. In patent law, obviousness asks whether someone would have had a reason, at the time of filing, to combine existing elements to arrive at your solution. Founders often underestimate their own innovations because hindsight makes a solved problem feel inevitable — but what looks obvious after the fact often wasn't obvious to anyone before it existed.
Not necessarily. Literal infringement requires a competitor to replicate every individual limitation listed in a patent's broadest claim. If a product has five patented components and a competitor only uses three, that may not constitute infringement — which is why a clear, well-scoped patent strategy matters as much as having a patent at all.
Ready to turn your product idea into a reality and get it to market? Contact us today at 52 Launch to get started.